Company intelligence / Profile preview
Risen-Sun Pharmaceutical
Nanjing, Jiangsu, Chinarisen-sun.com ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
Risen-Sun Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and commercialization of innovative drugs and high-quality generics. The company maintains a diverse portfolio spanning oncology, cardiovascular, and anti-infective therapeutic areas. Risen-Sun is particularly recognized for its efforts in developing targeted therapies for cancer, including small molecule inhibitors and biologics. With integrated capabilities in R&D and manufacturing, the company aims to provide affordable and effective treatment options for patients globally.
- Therapeutic areas
- Infectious DiseasesCardiovascularOncology
- Modalities
- Small moleculeMonoclonal antibody
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Risen-Sun Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Risen-Sun Pharmaceutical.